| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 464 | 2024 | 6987 | 30.820 |
Why?
|
| Psychotic Disorders | 310 | 2024 | 3279 | 29.420 |
Why?
|
| Schizophrenic Psychology | 135 | 2024 | 1652 | 13.610 |
Why?
|
| Bipolar Disorder | 139 | 2024 | 5126 | 8.270 |
Why?
|
| Psychiatry | 28 | 2024 | 1715 | 5.130 |
Why?
|
| Cognition Disorders | 79 | 2024 | 3985 | 5.080 |
Why?
|
| Antipsychotic Agents | 84 | 2024 | 3080 | 4.780 |
Why?
|
| Brain | 178 | 2024 | 27454 | 4.060 |
Why?
|
| Magnetic Resonance Imaging | 272 | 2024 | 36849 | 3.700 |
Why?
|
| Prefrontal Cortex | 58 | 2021 | 2257 | 3.190 |
Why?
|
| Child of Impaired Parents | 17 | 2012 | 463 | 3.090 |
Why?
|
| Psychiatric Status Rating Scales | 108 | 2023 | 6034 | 2.970 |
Why?
|
| Cognition | 72 | 2024 | 7075 | 2.930 |
Why?
|
| Frontal Lobe | 31 | 2018 | 1428 | 2.910 |
Why?
|
| Neuropsychological Tests | 121 | 2024 | 7145 | 2.800 |
Why?
|
| Mental Disorders | 39 | 2024 | 6876 | 2.680 |
Why?
|
| Temporal Lobe | 23 | 2018 | 1728 | 2.500 |
Why?
|
| Corpus Callosum | 28 | 2021 | 754 | 2.450 |
Why?
|
| Neurosciences | 8 | 2024 | 385 | 2.440 |
Why?
|
| Family | 46 | 2024 | 3208 | 2.400 |
Why?
|
| Humans | 853 | 2024 | 768393 | 2.340 |
Why?
|
| Yoga | 5 | 2024 | 280 | 2.280 |
Why?
|
| Hippocampus | 23 | 2023 | 3784 | 2.140 |
Why?
|
| Amygdala | 20 | 2022 | 1382 | 2.120 |
Why?
|
| Endophenotypes | 16 | 2022 | 258 | 2.110 |
Why?
|
| Cerebral Cortex | 40 | 2024 | 5831 | 1.910 |
Why?
|
| Adult | 451 | 2024 | 223640 | 1.900 |
Why?
|
| Social Perception | 14 | 2023 | 433 | 1.900 |
Why?
|
| Schizotypal Personality Disorder | 14 | 2013 | 289 | 1.850 |
Why?
|
| Pituitary Gland | 9 | 2024 | 634 | 1.840 |
Why?
|
| Adolescent | 282 | 2024 | 89184 | 1.820 |
Why?
|
| Theory of Mind | 8 | 2024 | 95 | 1.790 |
Why?
|
| Male | 531 | 2024 | 364902 | 1.750 |
Why?
|
| Neurologic Examination | 17 | 2019 | 916 | 1.740 |
Why?
|
| Autistic Disorder | 26 | 2023 | 1240 | 1.720 |
Why?
|
| Social Behavior | 20 | 2022 | 1146 | 1.710 |
Why?
|
| Young Adult | 175 | 2024 | 60049 | 1.700 |
Why?
|
| Nerve Net | 27 | 2021 | 2362 | 1.700 |
Why?
|
| Emotions | 26 | 2023 | 2768 | 1.700 |
Why?
|
| Image Processing, Computer-Assisted | 73 | 2023 | 9063 | 1.690 |
Why?
|
| Brain Mapping | 65 | 2023 | 6740 | 1.640 |
Why?
|
| Social Adjustment | 15 | 2024 | 636 | 1.630 |
Why?
|
| Female | 503 | 2024 | 397089 | 1.600 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 30 | 2017 | 1990 | 1.580 |
Why?
|
| Cholinergic Antagonists | 7 | 2023 | 167 | 1.560 |
Why?
|
| Magnetic Resonance Spectroscopy | 37 | 2018 | 3781 | 1.550 |
Why?
|
| DiGeorge Syndrome | 12 | 2024 | 187 | 1.540 |
Why?
|
| Memory, Short-Term | 20 | 2023 | 1010 | 1.470 |
Why?
|
| Family Health | 9 | 2015 | 1255 | 1.430 |
Why?
|
| Therapy, Computer-Assisted | 7 | 2017 | 265 | 1.420 |
Why?
|
| Meditation | 2 | 2024 | 257 | 1.410 |
Why?
|
| Neurology | 4 | 2023 | 786 | 1.380 |
Why?
|
| Phenotype | 43 | 2024 | 16721 | 1.370 |
Why?
|
| Neural Pathways | 24 | 2024 | 3121 | 1.320 |
Why?
|
| Longitudinal Studies | 71 | 2024 | 14784 | 1.300 |
Why?
|
| Hallucinations | 11 | 2023 | 375 | 1.280 |
Why?
|
| Cerebellum | 12 | 2024 | 1514 | 1.270 |
Why?
|
| Early Diagnosis | 16 | 2024 | 1195 | 1.260 |
Why?
|
| Organ Size | 24 | 2024 | 2268 | 1.200 |
Why?
|
| Functional Laterality | 41 | 2016 | 2268 | 1.140 |
Why?
|
| Clozapine | 5 | 2024 | 508 | 1.110 |
Why?
|
| Basal Ganglia | 11 | 2010 | 555 | 1.100 |
Why?
|
| Risperidone | 17 | 2024 | 383 | 1.090 |
Why?
|
| Evoked Potentials, Auditory | 11 | 2022 | 533 | 1.070 |
Why?
|
| Gyrus Cinguli | 22 | 2021 | 1137 | 1.060 |
Why?
|
| Choroid Plexus | 4 | 2023 | 250 | 1.060 |
Why?
|
| Nervous System Diseases | 12 | 2018 | 1664 | 1.040 |
Why?
|
| Thalamus | 16 | 2021 | 1050 | 1.030 |
Why?
|
| Cannabis | 5 | 2023 | 445 | 1.010 |
Why?
|
| Caregivers | 5 | 2024 | 2303 | 0.990 |
Why?
|
| Analysis of Variance | 44 | 2015 | 6241 | 0.940 |
Why?
|
| Intelligence | 8 | 2024 | 929 | 0.930 |
Why?
|
| Saccades | 19 | 2022 | 235 | 0.910 |
Why?
|
| Diffusion Tensor Imaging | 11 | 2022 | 2426 | 0.900 |
Why?
|
| Pursuit, Smooth | 8 | 2024 | 39 | 0.890 |
Why?
|
| Genetic Predisposition to Disease | 41 | 2019 | 18048 | 0.890 |
Why?
|
| Depressive Disorder | 28 | 2024 | 3736 | 0.890 |
Why?
|
| Affective Disorders, Psychotic | 9 | 2021 | 187 | 0.880 |
Why?
|
| Siblings | 4 | 2015 | 829 | 0.860 |
Why?
|
| Aspartic Acid | 12 | 2015 | 577 | 0.820 |
Why?
|
| Neuronal Plasticity | 8 | 2021 | 1448 | 0.820 |
Why?
|
| Sleep | 7 | 2024 | 4802 | 0.810 |
Why?
|
| Behavioral Symptoms | 3 | 2015 | 188 | 0.810 |
Why?
|
| Risk | 28 | 2024 | 9636 | 0.790 |
Why?
|
| Executive Function | 13 | 2022 | 1405 | 0.790 |
Why?
|
| Interpersonal Relations | 4 | 2017 | 1440 | 0.790 |
Why?
|
| Child | 133 | 2024 | 80891 | 0.780 |
Why?
|
| Case-Control Studies | 59 | 2024 | 22296 | 0.780 |
Why?
|
| Pattern Recognition, Visual | 8 | 2021 | 825 | 0.780 |
Why?
|
| Telemedicine | 9 | 2022 | 3107 | 0.770 |
Why?
|
| Neuropsychology | 2 | 2018 | 110 | 0.750 |
Why?
|
| Caudate Nucleus | 9 | 2016 | 392 | 0.750 |
Why?
|
| Emotional Intelligence | 5 | 2019 | 135 | 0.740 |
Why?
|
| Retina | 3 | 2024 | 2661 | 0.740 |
Why?
|
| Social Stigma | 4 | 2021 | 785 | 0.740 |
Why?
|
| Pilot Projects | 30 | 2023 | 8731 | 0.730 |
Why?
|
| Reference Values | 34 | 2015 | 4941 | 0.730 |
Why?
|
| Nerve Fibers, Myelinated | 5 | 2014 | 953 | 0.720 |
Why?
|
| Psychotherapy | 11 | 2024 | 1656 | 0.720 |
Why?
|
| Motor Cortex | 3 | 2019 | 1014 | 0.700 |
Why?
|
| Middle Aged | 169 | 2024 | 223491 | 0.700 |
Why?
|
| Mental Health Services | 8 | 2024 | 1731 | 0.700 |
Why?
|
| Mental Health | 9 | 2024 | 3276 | 0.700 |
Why?
|
| Principal Component Analysis | 7 | 2017 | 948 | 0.690 |
Why?
|
| Electroencephalography | 38 | 2024 | 6317 | 0.690 |
Why?
|
| Impulsive Behavior | 2 | 2015 | 349 | 0.680 |
Why?
|
| Auditory Cortex | 6 | 2020 | 365 | 0.650 |
Why?
|
| Facial Expression | 9 | 2021 | 515 | 0.650 |
Why?
|
| Statistics as Topic | 17 | 2017 | 2363 | 0.650 |
Why?
|
| Glutamic Acid | 7 | 2023 | 1193 | 0.640 |
Why?
|
| Obsessive-Compulsive Disorder | 14 | 2013 | 1509 | 0.640 |
Why?
|
| Psychopathology | 8 | 2024 | 435 | 0.640 |
Why?
|
| Sex Characteristics | 14 | 2024 | 2660 | 0.640 |
Why?
|
| Evoked Potentials, Motor | 2 | 2019 | 465 | 0.620 |
Why?
|
| Wakefulness | 4 | 2024 | 1283 | 0.620 |
Why?
|
| Thinking | 4 | 2023 | 320 | 0.620 |
Why?
|
| Self Concept | 4 | 2013 | 1047 | 0.610 |
Why?
|
| Dominance, Cerebral | 19 | 2017 | 624 | 0.610 |
Why?
|
| Memory Disorders | 10 | 2015 | 1203 | 0.600 |
Why?
|
| Data Collection | 4 | 2021 | 3324 | 0.600 |
Why?
|
| Marijuana Abuse | 4 | 2022 | 410 | 0.600 |
Why?
|
| Interdisciplinary Communication | 3 | 2020 | 937 | 0.600 |
Why?
|
| Corpus Striatum | 11 | 2021 | 1237 | 0.590 |
Why?
|
| Phospholipids | 11 | 2013 | 783 | 0.590 |
Why?
|
| Awareness | 7 | 2017 | 653 | 0.580 |
Why?
|
| Models, Psychological | 9 | 2015 | 828 | 0.580 |
Why?
|
| Social Control, Formal | 1 | 2018 | 107 | 0.580 |
Why?
|
| Evoked Potentials | 9 | 2023 | 1058 | 0.580 |
Why?
|
| Visual Cortex | 3 | 2022 | 1112 | 0.570 |
Why?
|
| Risk Factors | 61 | 2024 | 74962 | 0.570 |
Why?
|
| Health Services Accessibility | 6 | 2020 | 5512 | 0.570 |
Why?
|
| Catechol O-Methyltransferase | 6 | 2020 | 251 | 0.570 |
Why?
|
| Polymorphism, Single Nucleotide | 19 | 2020 | 16028 | 0.570 |
Why?
|
| Sleep, REM | 12 | 2007 | 595 | 0.560 |
Why?
|
| Delusions | 9 | 2022 | 301 | 0.560 |
Why?
|
| Parahippocampal Gyrus | 5 | 2016 | 118 | 0.560 |
Why?
|
| Protons | 4 | 2013 | 1112 | 0.550 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 1469 | 0.540 |
Why?
|
| Suicide, Attempted | 7 | 2024 | 1409 | 0.540 |
Why?
|
| Antimanic Agents | 4 | 2014 | 524 | 0.540 |
Why?
|
| Cross-Cultural Comparison | 4 | 2016 | 638 | 0.530 |
Why?
|
| Alcoholism | 7 | 2014 | 1982 | 0.530 |
Why?
|
| Group Homes | 1 | 2016 | 59 | 0.530 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2016 | 560 | 0.530 |
Why?
|
| Suicide | 6 | 2013 | 1607 | 0.520 |
Why?
|
| Disease Progression | 20 | 2024 | 13646 | 0.520 |
Why?
|
| Religion and Psychology | 3 | 2014 | 180 | 0.520 |
Why?
|
| Occipital Lobe | 4 | 2015 | 376 | 0.520 |
Why?
|
| Event-Related Potentials, P300 | 6 | 2023 | 149 | 0.520 |
Why?
|
| Comprehension | 3 | 2019 | 641 | 0.520 |
Why?
|
| Electromyography | 3 | 2018 | 1402 | 0.520 |
Why?
|
| Nerve Fibers, Unmyelinated | 3 | 2012 | 98 | 0.510 |
Why?
|
| Transcranial Magnetic Stimulation | 6 | 2022 | 1489 | 0.510 |
Why?
|
| Visual Pathways | 1 | 2020 | 559 | 0.510 |
Why?
|
| Reaction Time | 25 | 2021 | 2103 | 0.500 |
Why?
|
| Psychoses, Substance-Induced | 3 | 2019 | 98 | 0.500 |
Why?
|
| Anxiety Disorders | 9 | 2024 | 2754 | 0.500 |
Why?
|
| Verbal Learning | 4 | 2013 | 465 | 0.490 |
Why?
|
| Koro | 1 | 2014 | 1 | 0.490 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2010 | 607 | 0.490 |
Why?
|
| Stress Disorders, Post-Traumatic | 10 | 2023 | 4641 | 0.480 |
Why?
|
| Hinduism | 1 | 2014 | 14 | 0.470 |
Why?
|
| Factor Analysis, Statistical | 10 | 2019 | 1004 | 0.460 |
Why?
|
| Parietal Lobe | 7 | 2019 | 866 | 0.460 |
Why?
|
| Task Performance and Analysis | 3 | 2017 | 771 | 0.450 |
Why?
|
| Sleep Stages | 11 | 2005 | 705 | 0.450 |
Why?
|
| Art | 1 | 2014 | 64 | 0.450 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 10 | 2021 | 3743 | 0.450 |
Why?
|
| Learning | 6 | 2019 | 1761 | 0.440 |
Why?
|
| Attention | 21 | 2024 | 2425 | 0.440 |
Why?
|
| Philosophy | 2 | 2024 | 69 | 0.440 |
Why?
|
| Peer Group | 3 | 2024 | 698 | 0.440 |
Why?
|
| Drama | 1 | 2013 | 15 | 0.430 |
Why?
|
| Rest | 7 | 2024 | 951 | 0.430 |
Why?
|
| Age of Onset | 16 | 2022 | 3345 | 0.430 |
Why?
|
| Brain Diseases | 6 | 2023 | 1552 | 0.430 |
Why?
|
| Lithium Compounds | 1 | 2014 | 226 | 0.420 |
Why?
|
| Multifactorial Inheritance | 4 | 2022 | 1421 | 0.420 |
Why?
|
| Dyskinesia, Drug-Induced | 3 | 2009 | 165 | 0.420 |
Why?
|
| Memory | 8 | 2013 | 2210 | 0.420 |
Why?
|
| Imaging, Three-Dimensional | 10 | 2023 | 4076 | 0.420 |
Why?
|
| Environment | 2 | 2016 | 1124 | 0.420 |
Why?
|
| Judgment | 2 | 2021 | 272 | 0.420 |
Why?
|
| Delta Rhythm | 4 | 2015 | 82 | 0.410 |
Why?
|
| Cannabinoids | 2 | 2022 | 175 | 0.410 |
Why?
|
| Hepatic Encephalopathy | 1 | 2014 | 144 | 0.410 |
Why?
|
| Tomography, Optical Coherence | 3 | 2022 | 2957 | 0.410 |
Why?
|
| Psychomotor Performance | 14 | 2022 | 1895 | 0.400 |
Why?
|
| Brain Waves | 6 | 2024 | 418 | 0.400 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3118 | 0.400 |
Why?
|
| Polysomnography | 9 | 2024 | 1865 | 0.400 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3241 | 0.400 |
Why?
|
| Culture | 3 | 2011 | 623 | 0.390 |
Why?
|
| Editorial Policies | 1 | 2016 | 459 | 0.390 |
Why?
|
| Self Care | 1 | 2017 | 797 | 0.390 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 8 | 2024 | 2820 | 0.390 |
Why?
|
| Psychometrics | 11 | 2020 | 3069 | 0.390 |
Why?
|
| Hospitals, Psychiatric | 2 | 2012 | 318 | 0.390 |
Why?
|
| Limbic System | 7 | 2021 | 423 | 0.380 |
Why?
|
| Genetics | 1 | 2012 | 114 | 0.380 |
Why?
|
| Psychotropic Drugs | 4 | 2015 | 884 | 0.380 |
Why?
|
| Science | 1 | 2014 | 237 | 0.380 |
Why?
|
| Follow-Up Studies | 37 | 2024 | 39407 | 0.380 |
Why?
|
| Behavior Therapy | 1 | 2017 | 886 | 0.380 |
Why?
|
| Financing, Organized | 1 | 2013 | 203 | 0.380 |
Why?
|
| Asia | 4 | 2014 | 627 | 0.370 |
Why?
|
| Personal Construct Theory | 2 | 2007 | 9 | 0.370 |
Why?
|
| Mathematical Computing | 2 | 2008 | 142 | 0.370 |
Why?
|
| Language | 5 | 2021 | 1558 | 0.370 |
Why?
|
| Child Abuse | 10 | 2017 | 1096 | 0.370 |
Why?
|
| History, 20th Century | 8 | 2024 | 2771 | 0.370 |
Why?
|
| Oxygen | 15 | 2017 | 4273 | 0.370 |
Why?
|
| Adaptation, Psychological | 4 | 2018 | 2663 | 0.370 |
Why?
|
| Depressive Disorder, Major | 16 | 2024 | 4819 | 0.370 |
Why?
|
| Writing | 1 | 2013 | 200 | 0.360 |
Why?
|
| Membrane Lipids | 6 | 2006 | 251 | 0.360 |
Why?
|
| Treatment Outcome | 32 | 2024 | 65379 | 0.360 |
Why?
|
| Encephalitis | 1 | 2014 | 441 | 0.360 |
Why?
|
| Reproducibility of Results | 22 | 2023 | 20224 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 22 | 5 | 2013 | 348 | 0.360 |
Why?
|
| History, 21st Century | 7 | 2024 | 1575 | 0.360 |
Why?
|
| Septum Pellucidum | 2 | 2008 | 55 | 0.350 |
Why?
|
| Bullying | 3 | 2024 | 234 | 0.350 |
Why?
|
| RGS Proteins | 2 | 2013 | 76 | 0.350 |
Why?
|
| Depression | 8 | 2019 | 8241 | 0.340 |
Why?
|
| Anxiety | 5 | 2020 | 4677 | 0.340 |
Why?
|
| Paintings | 2 | 2014 | 103 | 0.340 |
Why?
|
| Disease Management | 2 | 2018 | 2537 | 0.340 |
Why?
|
| Computer-Assisted Instruction | 2 | 2010 | 364 | 0.340 |
Why?
|
| Inpatients | 2 | 2021 | 2570 | 0.340 |
Why?
|
| Cell Membrane | 6 | 2011 | 3663 | 0.340 |
Why?
|
| Mentors | 1 | 2015 | 672 | 0.340 |
Why?
|
| Massachusetts | 5 | 2024 | 8902 | 0.330 |
Why?
|
| Internship and Residency | 5 | 2020 | 5949 | 0.330 |
Why?
|
| Sex Factors | 22 | 2023 | 10654 | 0.330 |
Why?
|
| Music | 4 | 2020 | 247 | 0.330 |
Why?
|
| Heart Rate | 6 | 2019 | 4218 | 0.330 |
Why?
|
| Antioxidants | 3 | 2018 | 1673 | 0.330 |
Why?
|
| Benzodiazepines | 8 | 2020 | 1139 | 0.320 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2019 | 710 | 0.320 |
Why?
|
| Terminology as Topic | 3 | 2013 | 1539 | 0.320 |
Why?
|
| Psychopharmacology | 1 | 2010 | 146 | 0.320 |
Why?
|
| Personality Assessment | 3 | 2008 | 646 | 0.320 |
Why?
|
| Epidemics | 1 | 2014 | 517 | 0.310 |
Why?
|
| Severity of Illness Index | 30 | 2021 | 15939 | 0.310 |
Why?
|
| Time Factors | 29 | 2024 | 40272 | 0.310 |
Why?
|
| Phosphorus Isotopes | 5 | 2010 | 125 | 0.310 |
Why?
|
| Anisotropy | 8 | 2022 | 1296 | 0.310 |
Why?
|
| Recovery of Function | 1 | 2019 | 2990 | 0.310 |
Why?
|
| Affect | 7 | 2019 | 1501 | 0.310 |
Why?
|
| Speech Disorders | 1 | 2009 | 180 | 0.310 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 684 | 0.310 |
Why?
|
| Problem Solving | 2 | 2008 | 443 | 0.310 |
Why?
|
| Drug Discovery | 1 | 2016 | 1067 | 0.310 |
Why?
|
| Oxytocin | 3 | 2018 | 403 | 0.300 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2018 | 3520 | 0.300 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2008 | 174 | 0.300 |
Why?
|
| Reflex | 3 | 2006 | 375 | 0.300 |
Why?
|
| Affective Symptoms | 4 | 2019 | 418 | 0.300 |
Why?
|
| Age Factors | 31 | 2023 | 18471 | 0.300 |
Why?
|
| Grief | 2 | 2007 | 255 | 0.300 |
Why?
|
| China | 9 | 2020 | 2395 | 0.300 |
Why?
|
| Visual Perception | 7 | 2017 | 1406 | 0.290 |
Why?
|
| Spirituality | 1 | 2012 | 430 | 0.290 |
Why?
|
| Feasibility Studies | 9 | 2020 | 5313 | 0.290 |
Why?
|
| Cerebral Ventricles | 6 | 2001 | 550 | 0.290 |
Why?
|
| Speech Perception | 2 | 2016 | 512 | 0.290 |
Why?
|
| Dibenzothiazepines | 1 | 2007 | 102 | 0.290 |
Why?
|
| Prognosis | 17 | 2022 | 30022 | 0.280 |
Why?
|
| Neurobiology | 1 | 2008 | 137 | 0.280 |
Why?
|
| Research | 3 | 2013 | 1981 | 0.280 |
Why?
|
| Cluster Analysis | 4 | 2022 | 2728 | 0.280 |
Why?
|
| Schizophrenia, Paranoid | 2 | 2020 | 103 | 0.280 |
Why?
|
| Violence | 2 | 2013 | 938 | 0.280 |
Why?
|
| Medicine | 1 | 2015 | 948 | 0.280 |
Why?
|
| Pharmacogenetics | 3 | 2016 | 683 | 0.280 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2009 | 243 | 0.270 |
Why?
|
| Chromosome Deletion | 5 | 2013 | 1390 | 0.270 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2008 | 327 | 0.270 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2006 | 37 | 0.270 |
Why?
|
| Hydrocortisone | 7 | 2023 | 1841 | 0.270 |
Why?
|
| History, Ancient | 3 | 2017 | 213 | 0.270 |
Why?
|
| Phosphocreatine | 7 | 2010 | 261 | 0.260 |
Why?
|
| Lithium | 7 | 2005 | 600 | 0.260 |
Why?
|
| Pandemics | 3 | 2020 | 8753 | 0.260 |
Why?
|
| Language Disorders | 3 | 2013 | 140 | 0.250 |
Why?
|
| Conversion Disorder | 3 | 2019 | 202 | 0.250 |
Why?
|
| North America | 7 | 2023 | 1290 | 0.250 |
Why?
|
| Cortical Synchronization | 1 | 2005 | 78 | 0.250 |
Why?
|
| Hepatitis C, Chronic | 1 | 2014 | 1031 | 0.250 |
Why?
|
| Genetic Variation | 8 | 2018 | 6606 | 0.250 |
Why?
|
| Arginine Vasopressin | 2 | 2017 | 125 | 0.250 |
Why?
|
| Phosphorus | 6 | 2008 | 336 | 0.250 |
Why?
|
| Quinolones | 1 | 2009 | 382 | 0.250 |
Why?
|
| Motivation | 4 | 2024 | 2029 | 0.250 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 6 | 2007 | 1141 | 0.250 |
Why?
|
| Genotype | 16 | 2020 | 13042 | 0.240 |
Why?
|
| Beta Rhythm | 3 | 2019 | 65 | 0.240 |
Why?
|
| Hyperglycemia | 2 | 2020 | 1389 | 0.240 |
Why?
|
| Haloperidol | 9 | 2009 | 394 | 0.240 |
Why?
|
| Receptors, Metabotropic Glutamate | 3 | 2016 | 196 | 0.240 |
Why?
|
| Antidepressive Agents | 3 | 2016 | 2913 | 0.240 |
Why?
|
| Famous Persons | 1 | 2006 | 109 | 0.240 |
Why?
|
| Research Design | 6 | 2024 | 6210 | 0.240 |
Why?
|
| Auditory Pathways | 2 | 2021 | 238 | 0.240 |
Why?
|
| Predictive Value of Tests | 12 | 2021 | 15455 | 0.240 |
Why?
|
| Acoustic Stimulation | 9 | 2021 | 1253 | 0.240 |
Why?
|
| Brief Psychiatric Rating Scale | 7 | 2011 | 108 | 0.240 |
Why?
|
| Education, Medical | 2 | 2014 | 1742 | 0.240 |
Why?
|
| Herpesvirus 1, Human | 4 | 2012 | 744 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 7453 | 0.230 |
Why?
|
| Aging | 8 | 2021 | 8764 | 0.230 |
Why?
|
| Suicidal Ideation | 2 | 2024 | 1462 | 0.230 |
Why?
|
| Photic Stimulation | 11 | 2017 | 2004 | 0.230 |
Why?
|
| Curriculum | 2 | 2015 | 3776 | 0.230 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 1998 | 433 | 0.230 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2001 | 134 | 0.220 |
Why?
|
| History, 19th Century | 3 | 2017 | 715 | 0.220 |
Why?
|
| Putamen | 9 | 2019 | 293 | 0.220 |
Why?
|
| Lithium Chloride | 2 | 2002 | 83 | 0.220 |
Why?
|
| Dopamine | 6 | 2007 | 1617 | 0.220 |
Why?
|
| Stress, Psychological | 2 | 2023 | 4543 | 0.220 |
Why?
|
| Chi-Square Distribution | 9 | 2012 | 3438 | 0.210 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 429 | 0.210 |
Why?
|
| Cross-Sectional Studies | 15 | 2024 | 26375 | 0.210 |
Why?
|
| Inflammation | 4 | 2023 | 10863 | 0.210 |
Why?
|
| Models, Statistical | 4 | 2018 | 5099 | 0.210 |
Why?
|
| Quality of Life | 5 | 2024 | 13503 | 0.210 |
Why?
|
| Water | 4 | 2024 | 1418 | 0.210 |
Why?
|
| Drug Tolerance | 1 | 2004 | 366 | 0.210 |
Why?
|
| Brain Stem | 6 | 2013 | 862 | 0.210 |
Why?
|
| Intelligence Tests | 4 | 2012 | 505 | 0.210 |
Why?
|
| Professional Competence | 1 | 2006 | 430 | 0.210 |
Why?
|
| Heart Diseases | 1 | 2016 | 2819 | 0.210 |
Why?
|
| Avoidance Learning | 1 | 2024 | 249 | 0.210 |
Why?
|
| Parkinson Disease, Secondary | 2 | 1999 | 122 | 0.210 |
Why?
|
| Receptors, Muscarinic | 2 | 2012 | 157 | 0.210 |
Why?
|
| Entorhinal Cortex | 1 | 2004 | 288 | 0.210 |
Why?
|
| Spin Labels | 2 | 2023 | 339 | 0.200 |
Why?
|
| Apolipoproteins | 1 | 2005 | 328 | 0.200 |
Why?
|
| Electroretinography | 1 | 2024 | 524 | 0.200 |
Why?
|
| Pituitary-Adrenal System | 4 | 2013 | 557 | 0.200 |
Why?
|
| Glutathione | 2 | 2018 | 585 | 0.200 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 3922 | 0.200 |
Why?
|
| Expressed Emotion | 1 | 2022 | 92 | 0.200 |
Why?
|
| Syndrome | 4 | 2023 | 3275 | 0.200 |
Why?
|
| Phosphates | 2 | 2004 | 765 | 0.200 |
Why?
|
| Neurotransmitter Agents | 3 | 2011 | 665 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2022 | 24318 | 0.200 |
Why?
|
| Mood Disorders | 6 | 2017 | 1129 | 0.190 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 1988 | 628 | 0.190 |
Why?
|
| Panic Disorder | 1 | 2005 | 613 | 0.190 |
Why?
|
| India | 7 | 2016 | 2325 | 0.190 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1794 | 0.190 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2022 | 69 | 0.190 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2013 | 705 | 0.190 |
Why?
|
| Creatine | 7 | 2015 | 427 | 0.190 |
Why?
|
| Cerebellar Nuclei | 1 | 2021 | 54 | 0.190 |
Why?
|
| Knowledge | 1 | 2023 | 179 | 0.190 |
Why?
|
| Self Report | 6 | 2022 | 3766 | 0.190 |
Why?
|
| Energy Metabolism | 6 | 2012 | 2906 | 0.190 |
Why?
|
| Personality Disorders | 2 | 2005 | 729 | 0.190 |
Why?
|
| Linear Models | 8 | 2019 | 5878 | 0.190 |
Why?
|
| Atrophy | 6 | 2016 | 1648 | 0.190 |
Why?
|
| Obstetric Labor Complications | 1 | 2003 | 243 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 4 | 2023 | 2736 | 0.190 |
Why?
|
| Physicians | 2 | 2016 | 4614 | 0.180 |
Why?
|
| Fluphenazine | 3 | 2009 | 35 | 0.180 |
Why?
|
| Multilingualism | 1 | 2021 | 88 | 0.180 |
Why?
|
| Internal-External Control | 3 | 2008 | 350 | 0.180 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2021 | 115 | 0.180 |
Why?
|
| Tomography, Emission-Computed | 4 | 1999 | 1126 | 0.180 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 4429 | 0.180 |
Why?
|
| Lorazepam | 3 | 2002 | 155 | 0.180 |
Why?
|
| Prospective Studies | 16 | 2024 | 54920 | 0.170 |
Why?
|
| Ocular Motility Disorders | 2 | 2013 | 144 | 0.170 |
Why?
|
| Deception | 1 | 2021 | 100 | 0.170 |
Why?
|
| Arecoline | 3 | 1988 | 9 | 0.170 |
Why?
|
| Individuality | 2 | 2021 | 307 | 0.170 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2013 | 542 | 0.170 |
Why?
|
| Role | 2 | 2024 | 176 | 0.170 |
Why?
|
| Diabetes Complications | 1 | 2007 | 1322 | 0.170 |
Why?
|
| Transients and Migrants | 1 | 2022 | 170 | 0.170 |
Why?
|
| Logistic Models | 4 | 2024 | 13323 | 0.170 |
Why?
|
| Eye Movements | 7 | 2017 | 514 | 0.170 |
Why?
|
| Social Participation | 2 | 2023 | 187 | 0.170 |
Why?
|
| Clonidine | 3 | 2001 | 170 | 0.170 |
Why?
|
| Pleasure | 1 | 2019 | 41 | 0.170 |
Why?
|
| Glutamine | 3 | 2023 | 578 | 0.170 |
Why?
|
| Evidence-Based Practice | 1 | 2024 | 500 | 0.170 |
Why?
|
| Program Development | 2 | 2018 | 1298 | 0.170 |
Why?
|
| Adolescent Development | 3 | 2013 | 283 | 0.170 |
Why?
|
| Neural Inhibition | 4 | 2009 | 588 | 0.160 |
Why?
|
| Clomipramine | 2 | 1998 | 54 | 0.160 |
Why?
|
| Panic | 3 | 1989 | 103 | 0.160 |
Why?
|
| Reflex, Abnormal | 1 | 2019 | 83 | 0.160 |
Why?
|
| Remedial Teaching | 2 | 2010 | 16 | 0.160 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2019 | 122 | 0.160 |
Why?
|
| Psychophysiologic Disorders | 2 | 2017 | 223 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 1 | 2006 | 899 | 0.160 |
Why?
|
| Genome-Wide Association Study | 8 | 2021 | 12778 | 0.160 |
Why?
|
| Erythrocyte Membrane | 3 | 2004 | 438 | 0.160 |
Why?
|
| Autonomic Nervous System | 2 | 2019 | 709 | 0.160 |
Why?
|
| Minority Groups | 2 | 2023 | 1215 | 0.160 |
Why?
|
| Neurophysins | 1 | 2018 | 14 | 0.160 |
Why?
|
| Asperger Syndrome | 2 | 2010 | 57 | 0.160 |
Why?
|
| Abnormalities, Multiple | 3 | 2013 | 1424 | 0.160 |
Why?
|
| Internet | 3 | 2016 | 3107 | 0.160 |
Why?
|
| Attitude | 2 | 2021 | 772 | 0.150 |
Why?
|
| Lateral Ventricles | 1 | 2019 | 145 | 0.150 |
Why?
|
| Pregnenolone | 1 | 2018 | 27 | 0.150 |
Why?
|
| Regression Analysis | 4 | 2021 | 6350 | 0.150 |
Why?
|
| Hallucinogens | 1 | 2022 | 207 | 0.150 |
Why?
|
| Teaching | 2 | 2020 | 1172 | 0.150 |
Why?
|
| Self Efficacy | 1 | 2022 | 643 | 0.150 |
Why?
|
| Ownership | 1 | 2021 | 344 | 0.150 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2013 | 487 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2016 | 3231 | 0.150 |
Why?
|
| Piperazines | 1 | 2009 | 2552 | 0.150 |
Why?
|
| Dopamine Agents | 1 | 1999 | 190 | 0.150 |
Why?
|
| Motion Perception | 2 | 2020 | 379 | 0.150 |
Why?
|
| Purines | 2 | 2012 | 615 | 0.150 |
Why?
|
| Nerve Fibers | 2 | 2020 | 709 | 0.140 |
Why?
|
| Journalism, Medical | 1 | 2018 | 73 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2019 | 370 | 0.140 |
Why?
|
| Alcohol-Related Disorders | 1 | 2000 | 243 | 0.140 |
Why?
|
| Adenosine Triphosphate | 4 | 2010 | 2002 | 0.140 |
Why?
|
| Neocortex | 2 | 2020 | 417 | 0.140 |
Why?
|
| Catatonia | 2 | 2019 | 181 | 0.140 |
Why?
|
| Microvessels | 1 | 2022 | 586 | 0.140 |
Why?
|
| Pregnanolone | 1 | 2018 | 67 | 0.140 |
Why?
|
| Brain Chemistry | 4 | 2003 | 962 | 0.140 |
Why?
|
| Personal Autonomy | 1 | 2020 | 315 | 0.140 |
Why?
|
| Models, Neurological | 5 | 2017 | 1783 | 0.140 |
Why?
|
| Neostriatum | 2 | 2014 | 247 | 0.140 |
Why?
|
| Independent Living | 2 | 2020 | 580 | 0.140 |
Why?
|
| Auditory Perceptual Disorders | 1 | 1997 | 36 | 0.140 |
Why?
|
| Remission Induction | 2 | 2022 | 2407 | 0.140 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2017 | 108 | 0.140 |
Why?
|
| Vasopressins | 1 | 2018 | 358 | 0.140 |
Why?
|
| Personality | 2 | 2018 | 560 | 0.140 |
Why?
|
| 22q11 Deletion Syndrome | 1 | 2016 | 18 | 0.140 |
Why?
|
| Statistics, Nonparametric | 6 | 2017 | 2862 | 0.140 |
Why?
|
| Acetylcysteine | 1 | 2018 | 262 | 0.130 |
Why?
|
| Genetic Association Studies | 5 | 2019 | 2742 | 0.130 |
Why?
|
| Attitude to Health | 2 | 2007 | 2025 | 0.130 |
Why?
|
| Drug Administration Schedule | 4 | 2009 | 4859 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2012 | 3464 | 0.130 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 600 | 0.130 |
Why?
|
| Erythrocytes | 2 | 2005 | 2421 | 0.130 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2022 | 1735 | 0.130 |
Why?
|
| Herpes Simplex | 2 | 2012 | 470 | 0.130 |
Why?
|
| Ecosystem | 1 | 2020 | 494 | 0.130 |
Why?
|
| Dissociative Disorders | 1 | 2018 | 235 | 0.130 |
Why?
|
| Single-Blind Method | 3 | 2023 | 1585 | 0.130 |
Why?
|
| Retinal Vessels | 1 | 2022 | 864 | 0.130 |
Why?
|
| Interview, Psychological | 5 | 2018 | 812 | 0.130 |
Why?
|
| Complement System Proteins | 1 | 2019 | 738 | 0.130 |
Why?
|
| Encyclopedias as Topic | 1 | 2015 | 19 | 0.130 |
Why?
|
| Imagination | 1 | 1997 | 226 | 0.130 |
Why?
|
| Needs Assessment | 2 | 2019 | 1142 | 0.120 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 849 | 0.120 |
Why?
|
| Receptors, Glutamate | 1 | 2016 | 229 | 0.120 |
Why?
|
| Psychosomatic Medicine | 1 | 2015 | 72 | 0.120 |
Why?
|
| Serotonin | 4 | 2009 | 1045 | 0.120 |
Why?
|
| Prolactin | 2 | 2008 | 626 | 0.120 |
Why?
|
| Computers, Handheld | 1 | 2017 | 211 | 0.120 |
Why?
|
| Referral and Consultation | 3 | 2021 | 3627 | 0.120 |
Why?
|
| Income | 1 | 2024 | 1877 | 0.120 |
Why?
|
| Social Class | 4 | 2024 | 2009 | 0.120 |
Why?
|
| Recurrence | 6 | 2021 | 8506 | 0.120 |
Why?
|
| Galvanic Skin Response | 1 | 2017 | 359 | 0.120 |
Why?
|
| Computer Security | 1 | 2017 | 260 | 0.120 |
Why?
|
| Movement Disorders | 2 | 2018 | 464 | 0.120 |
Why?
|
| Geographic Information Systems | 1 | 2017 | 283 | 0.120 |
Why?
|
| Aged | 30 | 2021 | 171562 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 1084 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 5 | 2018 | 2708 | 0.120 |
Why?
|
| Synaptic Transmission | 4 | 2020 | 1175 | 0.120 |
Why?
|
| Histamine Antagonists | 1 | 2015 | 94 | 0.120 |
Why?
|
| Neuropsychiatry | 1 | 2015 | 76 | 0.120 |
Why?
|
| Monitoring, Physiologic | 2 | 2019 | 1795 | 0.120 |
Why?
|
| Protein Precursors | 1 | 2018 | 1134 | 0.110 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 242 | 0.110 |
Why?
|
| Body Temperature | 1 | 2017 | 781 | 0.110 |
Why?
|
| Animals | 13 | 2018 | 169337 | 0.110 |
Why?
|
| Phobic Disorders | 2 | 1986 | 441 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2017 | 3411 | 0.110 |
Why?
|
| Speech | 2 | 2017 | 558 | 0.110 |
Why?
|
| United States | 10 | 2024 | 73150 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 12241 | 0.110 |
Why?
|
| Progesterone | 1 | 2018 | 751 | 0.110 |
Why?
|
| Medical Informatics Applications | 1 | 2015 | 180 | 0.110 |
Why?
|
| Language Tests | 2 | 2013 | 193 | 0.110 |
Why?
|
| Theta Rhythm | 1 | 2015 | 222 | 0.110 |
Why?
|
| Schools | 1 | 2022 | 1496 | 0.110 |
Why?
|
| Databases as Topic | 1 | 2015 | 475 | 0.110 |
Why?
|
| Valine | 2 | 2012 | 410 | 0.110 |
Why?
|
| Neuroleptic Malignant Syndrome | 2 | 1994 | 74 | 0.110 |
Why?
|
| Thyrotropin-Releasing Hormone | 3 | 1988 | 139 | 0.110 |
Why?
|
| Kynurenine | 2 | 2011 | 142 | 0.110 |
Why?
|
| Actigraphy | 1 | 2017 | 526 | 0.100 |
Why?
|
| Clinical Protocols | 2 | 2016 | 1445 | 0.100 |
Why?
|
| Sensitivity and Specificity | 6 | 2021 | 14737 | 0.100 |
Why?
|
| Space Perception | 2 | 2006 | 467 | 0.100 |
Why?
|
| Benzazepines | 1 | 2015 | 311 | 0.100 |
Why?
|
| Outpatients | 4 | 2024 | 1604 | 0.100 |
Why?
|
| Social Environment | 3 | 2008 | 1018 | 0.100 |
Why?
|
| Radionuclide Imaging | 2 | 2010 | 1998 | 0.100 |
Why?
|
| Cholinesterases | 1 | 1992 | 32 | 0.100 |
Why?
|
| Synapses | 3 | 2007 | 1766 | 0.100 |
Why?
|
| Confidentiality | 1 | 2017 | 606 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2024 | 3131 | 0.100 |
Why?
|
| Ego | 1 | 2012 | 99 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2007 | 5924 | 0.100 |
Why?
|
| Regional Health Planning | 1 | 2013 | 96 | 0.100 |
Why?
|
| Plasmalogens | 1 | 2012 | 30 | 0.100 |
Why?
|
| Residence Characteristics | 2 | 2020 | 2122 | 0.100 |
Why?
|
| Health Care Costs | 2 | 2022 | 3267 | 0.100 |
Why?
|
| Education | 1 | 2015 | 535 | 0.100 |
Why?
|
| Motor Activity | 3 | 2018 | 2720 | 0.100 |
Why?
|
| Ecology | 1 | 2012 | 105 | 0.100 |
Why?
|
| Pennsylvania | 2 | 2024 | 615 | 0.100 |
Why?
|
| Regional Blood Flow | 2 | 2007 | 1502 | 0.100 |
Why?
|
| Anti-Anxiety Agents | 2 | 2002 | 405 | 0.100 |
Why?
|
| Pineal Gland | 1 | 2013 | 158 | 0.100 |
Why?
|
| Receptors, AMPA | 1 | 2013 | 335 | 0.100 |
Why?
|
| Electrooculography | 3 | 2008 | 113 | 0.100 |
Why?
|
| Oxidation-Reduction | 3 | 2018 | 2225 | 0.100 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 998 | 0.100 |
Why?
|
| Insulin | 1 | 2006 | 6607 | 0.100 |
Why?
|
| Electroconvulsive Therapy | 3 | 1994 | 502 | 0.100 |
Why?
|
| Creatine Kinase | 1 | 1994 | 685 | 0.100 |
Why?
|
| Wechsler Scales | 3 | 2008 | 258 | 0.100 |
Why?
|
| Cohort Studies | 11 | 2024 | 41795 | 0.100 |
Why?
|
| Remote Consultation | 1 | 2014 | 242 | 0.090 |
Why?
|
| Parents | 2 | 2023 | 3596 | 0.090 |
Why?
|
| Drug Therapy, Combination | 5 | 2012 | 6318 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18362 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2003 | 2059 | 0.090 |
Why?
|
| Portraits as Topic | 1 | 2011 | 32 | 0.090 |
Why?
|
| Delivery of Health Care | 3 | 2018 | 5375 | 0.090 |
Why?
|
| Dreams | 2 | 1990 | 146 | 0.090 |
Why?
|
| Acyclovir | 1 | 2012 | 267 | 0.090 |
Why?
|
| Dexamethasone | 2 | 1989 | 1965 | 0.090 |
Why?
|
| Evoked Potentials, Visual | 3 | 2023 | 420 | 0.090 |
Why?
|
| Observer Variation | 4 | 2018 | 2623 | 0.090 |
Why?
|
| Employment | 1 | 2017 | 1116 | 0.090 |
Why?
|
| Cephalometry | 2 | 2004 | 380 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2009 | 10776 | 0.090 |
Why?
|
| Sample Size | 2 | 2020 | 848 | 0.090 |
Why?
|
| Desipramine | 2 | 1988 | 183 | 0.090 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2011 | 65 | 0.090 |
Why?
|
| Object Attachment | 1 | 2014 | 333 | 0.090 |
Why?
|
| Health Surveys | 1 | 2021 | 4056 | 0.090 |
Why?
|
| Elephants | 1 | 2011 | 41 | 0.090 |
Why?
|
| Tryptophan | 2 | 2011 | 482 | 0.090 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 303 | 0.090 |
Why?
|
| Oxidative Stress | 3 | 2011 | 3139 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 10377 | 0.090 |
Why?
|
| Acyltransferases | 1 | 2012 | 306 | 0.090 |
Why?
|
| Negotiating | 1 | 2012 | 152 | 0.090 |
Why?
|
| Communication | 2 | 2024 | 3912 | 0.090 |
Why?
|
| Chromatography, Gas | 3 | 2005 | 150 | 0.090 |
Why?
|
| Social Support | 3 | 2010 | 2191 | 0.090 |
Why?
|
| Receptors, Cholinergic | 2 | 1988 | 244 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 260 | 0.090 |
Why?
|
| Dipeptides | 1 | 2012 | 386 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 2 | 2024 | 1364 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 5538 | 0.090 |
Why?
|
| Anemia, Hypochromic | 1 | 1989 | 63 | 0.090 |
Why?
|
| Chlorpromazine | 2 | 2014 | 111 | 0.080 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 31 | 0.080 |
Why?
|
| Resilience, Psychological | 1 | 2018 | 805 | 0.080 |
Why?
|
| Fixation, Ocular | 4 | 2008 | 243 | 0.080 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1989 | 67 | 0.080 |
Why?
|
| Auditory Perception | 4 | 2019 | 588 | 0.080 |
Why?
|
| Fear | 2 | 1989 | 1494 | 0.080 |
Why?
|
| Circadian Rhythm | 3 | 2019 | 2588 | 0.080 |
Why?
|
| Semantics | 2 | 2013 | 618 | 0.080 |
Why?
|
| Paroxetine | 2 | 2000 | 181 | 0.080 |
Why?
|
| Boston | 3 | 2021 | 9371 | 0.080 |
Why?
|
| Psychotherapy, Group | 2 | 2010 | 414 | 0.080 |
Why?
|
| Patient Participation | 1 | 2018 | 1448 | 0.080 |
Why?
|
| Sensory Gating | 1 | 2009 | 47 | 0.080 |
Why?
|
| Illness Behavior | 1 | 2009 | 23 | 0.080 |
Why?
|
| Magic | 1 | 1989 | 14 | 0.080 |
Why?
|
| Pregnancy | 5 | 2023 | 30200 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 957 | 0.080 |
Why?
|
| Thyrotropin | 3 | 1988 | 834 | 0.080 |
Why?
|
| Child Development | 3 | 2013 | 2334 | 0.080 |
Why?
|
| Multivariate Analysis | 8 | 2019 | 12092 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 15649 | 0.080 |
Why?
|
| Comorbidity | 9 | 2009 | 10588 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1315 | 0.080 |
Why?
|
| Ganglia | 1 | 2008 | 86 | 0.080 |
Why?
|
| Phosphatidylethanolamines | 3 | 2013 | 131 | 0.080 |
Why?
|
| Disabled Children | 1 | 2011 | 251 | 0.080 |
Why?
|
| Medicine, Traditional | 1 | 1989 | 89 | 0.080 |
Why?
|
| Borderline Personality Disorder | 2 | 2007 | 767 | 0.080 |
Why?
|
| Extrapyramidal Tracts | 1 | 2008 | 17 | 0.080 |
Why?
|
| Cause of Death | 1 | 2019 | 3728 | 0.080 |
Why?
|
| Oculomotor Muscles | 2 | 2005 | 405 | 0.080 |
Why?
|
| Diagnosis, Differential | 8 | 2021 | 13020 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2021 | 3476 | 0.080 |
Why?
|
| Discriminant Analysis | 3 | 2013 | 222 | 0.080 |
Why?
|
| Prevalence | 4 | 2024 | 15872 | 0.070 |
Why?
|
| Nervous System Malformations | 1 | 2010 | 244 | 0.070 |
Why?
|
| Patient Preference | 1 | 2015 | 947 | 0.070 |
Why?
|
| Ear, External | 1 | 1988 | 165 | 0.070 |
Why?
|
| Hand Dermatoses | 1 | 1988 | 61 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 835 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2022 | 3857 | 0.070 |
Why?
|
| Diazepam | 1 | 1988 | 214 | 0.070 |
Why?
|
| Tic Disorders | 1 | 1988 | 140 | 0.070 |
Why?
|
| Isoenzymes | 1 | 1992 | 1684 | 0.070 |
Why?
|
| Mental Recall | 2 | 2014 | 1226 | 0.070 |
Why?
|
| Thyroid Function Tests | 1 | 1988 | 289 | 0.070 |
Why?
|
| Prenatal Care | 1 | 2015 | 1159 | 0.070 |
Why?
|
| Proteins | 2 | 2012 | 6006 | 0.070 |
Why?
|
| Transsexualism | 1 | 1991 | 210 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3164 | 0.070 |
Why?
|
| Cross-Over Studies | 2 | 2023 | 2106 | 0.070 |
Why?
|
| Dihydroergotoxine | 1 | 1986 | 21 | 0.070 |
Why?
|
| Weight Gain | 2 | 2008 | 2356 | 0.070 |
Why?
|
| Models, Theoretical | 4 | 2021 | 3579 | 0.070 |
Why?
|
| Chronic Disease | 6 | 2012 | 9379 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 6567 | 0.070 |
Why?
|
| Phencyclidine Abuse | 1 | 1986 | 8 | 0.070 |
Why?
|
| Cyclothymic Disorder | 2 | 2017 | 42 | 0.070 |
Why?
|
| Child Behavior Disorders | 2 | 2010 | 813 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2008 | 137 | 0.070 |
Why?
|
| Platelet Aggregation | 2 | 2007 | 769 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3707 | 0.070 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 563 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1753 | 0.070 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1987 | 92 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 1407 | 0.070 |
Why?
|
| Phencyclidine | 1 | 1986 | 59 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2022 | 8562 | 0.070 |
Why?
|
| Hepacivirus | 1 | 2014 | 1342 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2014 | 8075 | 0.070 |
Why?
|
| Myelin Sheath | 4 | 2021 | 653 | 0.070 |
Why?
|
| MEDLINE | 1 | 2006 | 119 | 0.070 |
Why?
|
| Genetic Counseling | 1 | 2010 | 634 | 0.070 |
Why?
|
| Trihexyphenidyl | 1 | 1985 | 4 | 0.070 |
Why?
|
| Lipid Metabolism | 2 | 2013 | 1901 | 0.070 |
Why?
|
| Orientation | 1 | 2008 | 320 | 0.070 |
Why?
|
| Demography | 4 | 2021 | 1642 | 0.070 |
Why?
|
| Diseases in Twins | 1 | 2008 | 447 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2011 | 1004 | 0.060 |
Why?
|
| Cholinergic Fibers | 1 | 1985 | 69 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2023 | 26411 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2011 | 1186 | 0.060 |
Why?
|
| Publishing | 1 | 2013 | 836 | 0.060 |
Why?
|
| Child Behavior | 1 | 2011 | 865 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 1389 | 0.060 |
Why?
|
| Pedigree | 3 | 2012 | 4544 | 0.060 |
Why?
|
| Apolipoproteins D | 1 | 2005 | 14 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3440 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2009 | 3541 | 0.060 |
Why?
|
| Electrocardiography | 4 | 2009 | 6409 | 0.060 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 472 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3413 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3230 | 0.060 |
Why?
|
| Dendrites | 1 | 2007 | 472 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2016 | 9682 | 0.060 |
Why?
|
| Health Status | 1 | 2017 | 4094 | 0.060 |
Why?
|
| Bibliometrics | 1 | 2008 | 355 | 0.060 |
Why?
|
| Vitamin B 12 | 1 | 2007 | 527 | 0.060 |
Why?
|
| Amino Acids, Essential | 1 | 2004 | 26 | 0.060 |
Why?
|
| Facial Muscles | 1 | 2004 | 159 | 0.060 |
Why?
|
| Students | 1 | 2014 | 1744 | 0.060 |
Why?
|
| Nonlinear Dynamics | 2 | 2017 | 494 | 0.060 |
Why?
|
| Gene Frequency | 3 | 2020 | 3617 | 0.060 |
Why?
|
| Middle East | 1 | 2024 | 233 | 0.060 |
Why?
|
| ROC Curve | 1 | 2011 | 3623 | 0.050 |
Why?
|
| Trifluoperazine | 1 | 1983 | 40 | 0.050 |
Why?
|
| Fatty Acids, Essential | 1 | 2003 | 97 | 0.050 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5891 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2010 | 1362 | 0.050 |
Why?
|
| Behavior Control | 1 | 2023 | 46 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 2146 | 0.050 |
Why?
|
| Depersonalization | 1 | 1983 | 40 | 0.050 |
Why?
|
| Cytokines | 1 | 2018 | 7445 | 0.050 |
Why?
|
| Verbal Behavior | 1 | 2004 | 336 | 0.050 |
Why?
|
| Motor Skills Disorders | 1 | 2003 | 89 | 0.050 |
Why?
|
| International Cooperation | 2 | 2024 | 1438 | 0.050 |
Why?
|
| Blinking | 1 | 1983 | 134 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2144 | 0.050 |
Why?
|
| Acute Disease | 4 | 2020 | 7242 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2890 | 0.050 |
Why?
|
| Algorithms | 4 | 2023 | 14154 | 0.050 |
Why?
|
| Cadmium | 1 | 2023 | 217 | 0.050 |
Why?
|
| Matched-Pair Analysis | 2 | 2005 | 286 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 1434 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2008 | 1838 | 0.050 |
Why?
|
| Psychological Techniques | 1 | 2021 | 48 | 0.050 |
Why?
|
| Cues | 2 | 2007 | 884 | 0.050 |
Why?
|
| Consensus | 3 | 2018 | 3212 | 0.050 |
Why?
|
| Astronomy | 1 | 1981 | 5 | 0.050 |
Why?
|
| Vitamin D | 1 | 2015 | 3310 | 0.050 |
Why?
|
| Catecholamines | 2 | 1999 | 390 | 0.050 |
Why?
|
| Software | 4 | 2008 | 4453 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 1882 | 0.050 |
Why?
|
| Probability | 3 | 2023 | 2482 | 0.050 |
Why?
|
| Students, Medical | 1 | 1994 | 1964 | 0.050 |
Why?
|
| Somatosensory Cortex | 1 | 2005 | 516 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2014 | 1496 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2024 | 373 | 0.040 |
Why?
|
| Radiography | 3 | 2007 | 6993 | 0.040 |
Why?
|
| Axilla | 1 | 2023 | 628 | 0.040 |
Why?
|
| Protein Binding | 1 | 2012 | 9343 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 2488 | 0.040 |
Why?
|
| Isotopes | 1 | 2000 | 125 | 0.040 |
Why?
|
| Genome | 1 | 2008 | 1747 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2001 | 177 | 0.040 |
Why?
|
| Pons | 1 | 2001 | 242 | 0.040 |
Why?
|
| Neurons | 4 | 2007 | 9513 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2024 | 81801 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1988 | 2202 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2015 | 4848 | 0.040 |
Why?
|
| Medulla Oblongata | 1 | 2001 | 248 | 0.040 |
Why?
|
| Cell Division | 1 | 2007 | 4479 | 0.040 |
Why?
|
| Meningioma | 1 | 1988 | 1221 | 0.040 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2016 | 300 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2012 | 3064 | 0.040 |
Why?
|
| Physician's Role | 1 | 2006 | 926 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 2258 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 1988 | 1253 | 0.040 |
Why?
|
| Plants | 1 | 2020 | 332 | 0.040 |
Why?
|
| Arousal | 3 | 1997 | 1183 | 0.040 |
Why?
|
| Hospitalization | 3 | 2024 | 10844 | 0.040 |
Why?
|
| Acoustics | 1 | 2019 | 244 | 0.040 |
Why?
|
| Consumer Advocacy | 1 | 2018 | 83 | 0.040 |
Why?
|
| Self-Injurious Behavior | 1 | 2024 | 568 | 0.040 |
Why?
|
| Echo-Planar Imaging | 1 | 2002 | 669 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2021 | 42650 | 0.040 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 1998 | 139 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 420 | 0.040 |
Why?
|
| Magnetics | 1 | 1981 | 599 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 1539 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 1983 | 774 | 0.040 |
Why?
|
| Cities | 1 | 2020 | 543 | 0.040 |
Why?
|
| Puberty | 1 | 2001 | 502 | 0.040 |
Why?
|
| Brain Damage, Chronic | 2 | 1996 | 267 | 0.040 |
Why?
|
| Visual Fields | 2 | 2009 | 1067 | 0.040 |
Why?
|
| Developing Countries | 2 | 2020 | 2903 | 0.040 |
Why?
|
| Nasal Provocation Tests | 1 | 2017 | 9 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3813 | 0.040 |
Why?
|
| Patient Admission | 2 | 1997 | 1367 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2019 | 565 | 0.040 |
Why?
|
| Reality Testing | 1 | 1997 | 24 | 0.040 |
Why?
|
| Episode of Care | 1 | 1998 | 128 | 0.030 |
Why?
|
| History, Medieval | 1 | 2017 | 62 | 0.030 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 162 | 0.030 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2018 | 241 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2007 | 2181 | 0.030 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 259 | 0.030 |
Why?
|
| Patient Rights | 1 | 2017 | 126 | 0.030 |
Why?
|
| beta-Lactamases | 1 | 2019 | 307 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2018 | 259 | 0.030 |
Why?
|
| Gene Expression | 2 | 2012 | 7598 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2007 | 2476 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3794 | 0.030 |
Why?
|
| Angiography | 1 | 2022 | 1598 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 1981 | 495 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 2337 | 0.030 |
Why?
|
| Binding Sites | 1 | 2005 | 6017 | 0.030 |
Why?
|
| Image Enhancement | 2 | 2004 | 2894 | 0.030 |
Why?
|
| Health Occupations | 1 | 2017 | 225 | 0.030 |
Why?
|
| Sampling Studies | 1 | 1997 | 616 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2019 | 1090 | 0.030 |
Why?
|
| Physical Examination | 1 | 2002 | 1262 | 0.030 |
Why?
|
| Age Distribution | 1 | 2021 | 2877 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2017 | 449 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7880 | 0.030 |
Why?
|
| Personality Inventory | 2 | 2013 | 1018 | 0.030 |
Why?
|
| Choline | 2 | 2008 | 518 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2011 | 23631 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2024 | 1099 | 0.030 |
Why?
|
| Feedback | 1 | 2018 | 795 | 0.030 |
Why?
|
| Relaxation | 1 | 1994 | 51 | 0.030 |
Why?
|
| Tourette Syndrome | 1 | 1998 | 400 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 905 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1980 | 716 | 0.030 |
Why?
|
| Developmental Disabilities | 2 | 2005 | 1516 | 0.030 |
Why?
|
| Educational Status | 3 | 2013 | 2518 | 0.030 |
Why?
|
| Glycerylphosphorylcholine | 1 | 2013 | 25 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2007 | 6670 | 0.030 |
Why?
|
| Movement | 1 | 2021 | 1490 | 0.030 |
Why?
|
| Perception | 1 | 2000 | 1205 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2021 | 1187 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2018 | 2693 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 798 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 2018 | 726 | 0.030 |
Why?
|
| Receptors, Dopamine | 1 | 1994 | 296 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 1983 | 1762 | 0.030 |
Why?
|
| Alleles | 2 | 2019 | 6892 | 0.030 |
Why?
|
| Rural Population | 2 | 2020 | 2318 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2015 | 361 | 0.030 |
Why?
|
| Axons | 1 | 2021 | 1678 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2018 | 12456 | 0.030 |
Why?
|
| Electronic Mail | 1 | 2014 | 215 | 0.030 |
Why?
|
| Nuclear Family | 1 | 2013 | 311 | 0.030 |
Why?
|
| Specialty Boards | 1 | 1994 | 236 | 0.030 |
Why?
|
| Marital Status | 1 | 2013 | 426 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2014 | 643 | 0.020 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2013 | 225 | 0.020 |
Why?
|
| Electrochemical Techniques | 1 | 2012 | 95 | 0.020 |
Why?
|
| Smell | 1 | 1994 | 261 | 0.020 |
Why?
|
| Health Promotion | 1 | 2024 | 2209 | 0.020 |
Why?
|
| Life Change Events | 1 | 2017 | 962 | 0.020 |
Why?
|
| Cardiolipins | 1 | 1991 | 83 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 1986 | 2895 | 0.020 |
Why?
|
| Longevity | 1 | 2019 | 1077 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 1994 | 367 | 0.020 |
Why?
|
| Multigene Family | 1 | 2015 | 1082 | 0.020 |
Why?
|
| Globus Pallidus | 2 | 2003 | 250 | 0.020 |
Why?
|
| Dystonia | 1 | 1994 | 378 | 0.020 |
Why?
|
| Technology, Radiologic | 1 | 1991 | 160 | 0.020 |
Why?
|
| Uric Acid | 2 | 2010 | 806 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1991 | 20765 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2012 | 406 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2022 | 2189 | 0.020 |
Why?
|
| Hypoxanthine | 1 | 2010 | 28 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2012 | 324 | 0.020 |
Why?
|
| Guanosine | 1 | 2010 | 43 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2015 | 1184 | 0.020 |
Why?
|
| Homeostasis | 2 | 2012 | 3349 | 0.020 |
Why?
|
| Cell Count | 1 | 1994 | 1833 | 0.020 |
Why?
|
| Xanthines | 1 | 2010 | 120 | 0.020 |
Why?
|
| Electrodes | 1 | 2012 | 617 | 0.020 |
Why?
|
| Ribonucleosides | 1 | 2010 | 79 | 0.020 |
Why?
|
| Empathy | 1 | 1994 | 476 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2006 | 4748 | 0.020 |
Why?
|
| Length of Stay | 1 | 2023 | 6519 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2009 | 94 | 0.020 |
Why?
|
| Vocabulary | 1 | 2009 | 167 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3587 | 0.020 |
Why?
|
| Stereotyped Behavior | 1 | 2009 | 135 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 1989 | 145 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2015 | 864 | 0.020 |
Why?
|
| Metabolism | 1 | 2010 | 193 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2015 | 3102 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 1998 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2009 | 187 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2009 | 440 | 0.020 |
Why?
|
| Forecasting | 1 | 2017 | 2948 | 0.020 |
Why?
|
| Clinical Clerkship | 1 | 1994 | 566 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 1988 | 109 | 0.020 |
Why?
|
| Seizures | 1 | 1981 | 3000 | 0.020 |
Why?
|
| Face | 1 | 2014 | 1031 | 0.020 |
Why?
|
| Methionine | 1 | 2010 | 573 | 0.020 |
Why?
|
| Nomifensine | 1 | 1987 | 14 | 0.020 |
Why?
|
| Perphenazine | 1 | 2007 | 33 | 0.020 |
Why?
|
| PubMed | 1 | 2008 | 130 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 1190 | 0.020 |
Why?
|
| Causality | 2 | 2004 | 1255 | 0.020 |
Why?
|
| Educational Measurement | 1 | 1994 | 1256 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 1140 | 0.020 |
Why?
|
| Stomatitis, Aphthous | 1 | 1987 | 51 | 0.020 |
Why?
|
| Ear Diseases | 1 | 1988 | 181 | 0.020 |
Why?
|
| Psychoanalytic Interpretation | 1 | 1986 | 55 | 0.020 |
Why?
|
| Oculomotor Nerve | 1 | 2006 | 72 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1991 | 1528 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1988 | 492 | 0.020 |
Why?
|
| Agoraphobia | 1 | 1986 | 177 | 0.020 |
Why?
|
| Alzheimer Disease | 2 | 1993 | 8747 | 0.020 |
Why?
|
| Perceptual Disorders | 1 | 2008 | 199 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1988 | 15881 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2007 | 193 | 0.020 |
Why?
|
| Pulmonary Atelectasis | 1 | 1987 | 160 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2007 | 422 | 0.020 |
Why?
|
| Somatoform Disorders | 1 | 1989 | 425 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5451 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1515 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2020 | 6430 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2011 | 1261 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 59686 | 0.020 |
Why?
|
| Gender Identity | 1 | 1991 | 770 | 0.020 |
Why?
|
| Legislation, Drug | 1 | 1987 | 216 | 0.010 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2006 | 305 | 0.010 |
Why?
|
| England | 1 | 1986 | 532 | 0.010 |
Why?
|
| Thyroxine | 1 | 1988 | 665 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2006 | 562 | 0.010 |
Why?
|
| Blindness | 1 | 1988 | 587 | 0.010 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 208 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2013 | 1398 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2012 | 2353 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 82017 | 0.010 |
Why?
|
| Melatonin | 1 | 2009 | 669 | 0.010 |
Why?
|
| Genetic Load | 1 | 2003 | 15 | 0.010 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1983 | 144 | 0.010 |
Why?
|
| Cotinine | 1 | 2004 | 206 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 1983 | 115 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1987 | 2226 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1991 | 2126 | 0.010 |
Why?
|
| Valproic Acid | 1 | 2005 | 443 | 0.010 |
Why?
|
| Computer Graphics | 1 | 2004 | 338 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2009 | 1748 | 0.010 |
Why?
|
| Metabolomics | 1 | 2012 | 1674 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 1447 | 0.010 |
Why?
|
| Models, Biological | 1 | 2019 | 9493 | 0.010 |
Why?
|
| Automation | 1 | 2004 | 588 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2012 | 13052 | 0.010 |
Why?
|
| Penis | 1 | 1983 | 210 | 0.010 |
Why?
|
| Occupations | 1 | 2004 | 519 | 0.010 |
Why?
|
| Astronomical Phenomena | 1 | 1981 | 1 | 0.010 |
Why?
|
| Bilirubin | 1 | 2003 | 438 | 0.010 |
Why?
|
| Electroshock | 1 | 1981 | 120 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2005 | 750 | 0.010 |
Why?
|
| Iron | 1 | 1989 | 1814 | 0.010 |
Why?
|
| Albumins | 1 | 2003 | 577 | 0.010 |
Why?
|
| Computational Biology | 1 | 2012 | 3543 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4570 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 3827 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 3442 | 0.010 |
Why?
|
| Dementia | 1 | 1993 | 2729 | 0.010 |
Why?
|
| Body Image | 1 | 1983 | 646 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 5800 | 0.010 |
Why?
|
| Smoking | 2 | 2010 | 9111 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2004 | 907 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1999 | 900 | 0.010 |
Why?
|
| Child Abuse, Sexual | 1 | 1999 | 404 | 0.010 |
Why?
|
| Patients | 1 | 2002 | 909 | 0.010 |
Why?
|
| Epinephrine | 1 | 1999 | 794 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2005 | 1923 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 4250 | 0.010 |
Why?
|
| Biperiden | 1 | 1994 | 1 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2006 | 3211 | 0.010 |
Why?
|
| New York | 1 | 1997 | 884 | 0.010 |
Why?
|
| Sensory Thresholds | 1 | 1994 | 377 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 8090 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1997 | 2604 | 0.010 |
Why?
|
| Placebos | 1 | 1994 | 1668 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2003 | 2537 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 21544 | 0.010 |
Why?
|
| Phenelzine | 1 | 1987 | 28 | 0.000 |
Why?
|
| Symbolism | 1 | 1986 | 34 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1997 | 2784 | 0.000 |
Why?
|
| Lithium Carbonate | 1 | 1986 | 179 | 0.000 |
Why?
|
| Rats | 1 | 1981 | 23835 | 0.000 |
Why?
|
| Acetylcholine | 1 | 1987 | 629 | 0.000 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 1983 | 110 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1991 | 2257 | 0.000 |
Why?
|